Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2012
05/23/2012CN102462819A 一种治疗中耳炎的中药组合物 One kind of traditional Chinese medicine composition for treatment of otitis media
05/23/2012CN102462778A 一种抗衰老补酒 An anti-aging tonic
05/23/2012CN102462763A 治疗角膜炎的药 Keratitis drug treatment
05/23/2012CN102462659A 一种胞磷胆碱钠注射液及其制备方法 A citicoline sodium injection and preparation method intracellular
05/23/2012CN102462279A 一种亚麻保健枕套 One kind of health care linen pillowcase
05/23/2012CN102178863B Method for preparing traditional Chinese medicine for treating liver-meridian and heat stagnation type tympanitis
05/23/2012CN102139013B Health care tonic wine for strengthening yang
05/23/2012CN102114193B Traditional Chinese medicine for treating keratomalacia due to vitamin A deficiency
05/23/2012CN102091214B Medicament for improving eyesight
05/23/2012CN102000279B Traditional Chinese medicine for treating myopia eye diseases
05/23/2012CN102000278B Traditional Chinese medicine for treating amblyopia eye diseases
05/23/2012CN101953990B Dynawave visual rehabilitation instrument and traditional Chinese medicine compound
05/23/2012CN101948539B IL-18 binding proteins
05/23/2012CN101897896B Chinese medicinal composition for treating cataract and medicinal preparation and preparation method thereof
05/23/2012CN101797223B Huperzine A preparations for eyes and application thereof
05/23/2012CN101757076B Turnip seed chewable tablet
05/23/2012CN101724653B Medicament containing natriuretic peptide gene as well as preparation method and application thereof
05/23/2012CN101433567B Clinical novel use of soft capsule for removing thromboembolism
05/23/2012CN101282716B Pharmaceutical composition of pranlukast solid-dispersion with improved initial dissolution rate and the method of preparing the same
05/23/2012CN101199848B Drug compound for Ca channel retarder/diuretic/ folate coupling and function
05/23/2012CN101199505B Verapamil liposome and preparing method thereof
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101103013B 1-thio-D-glucitol derivatives
05/22/2012US8183343 Methods for treating a skin wound
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183291 Clear ophthalmic solution comprising latanoprost as active ingredient
05/22/2012US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
05/22/2012CA2632949C Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
05/22/2012CA2592069C A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/22/2012CA2436107C Kyberdrug as autovaccines with immune-regulating effects
05/18/2012WO2012065106A2 Compounds and related methods for manipulating parp-1-dependent cell death
05/18/2012WO2012063896A1 Novel pyrazole amide derivative
05/18/2012WO2012063217A1 Composition for treating phonatory and olfactory apparatus disorders
05/18/2012WO2012038512A3 Composition comprising sod, lutein and zeaxanthin
05/18/2012WO2011091225A3 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122976 Phosphate-free pharmaceutical composition for the treatment of glaucoma
05/17/2012US20120122964 Bicyclic compound and use thereof for medical purposes
05/17/2012US20120122961 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
05/17/2012US20120122945 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
05/17/2012US20120122938 Alkoxy Compounds for Disease Treatment
05/17/2012US20120122934 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122922 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122898 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122826 Novel quinuclidine derivatives and medicinal compositions containing the same
05/17/2012US20120122821 Steroid-containing sustained release intraocular implants and related methods
05/17/2012US20120122815 Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
05/17/2012US20120122781 Peptide ligands of somatostatin receptors
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121708 Acetazolamide Microparticle And Its Preparation Method And Use
05/17/2012US20120121694 Compositions and Kits for Ocular Treatment
05/17/2012US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121567 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
05/17/2012US20120121562 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121542 Red-shifted opsin molecules and uses thereof
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
05/16/2012EP2452669A1 Ophthalmic composition
05/16/2012EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
05/16/2012EP2451463A2 Ophthalmic ethyleneoxide butyleneoxide block copolymer compositions
05/16/2012CN102459334A 靶定补体蛋白c3b的抗体的组合物和方法 Antibody compositions and methods of targeting of complement proteins c3b
05/16/2012CN102459252A 用于治疗糖原合酶激酶3相关疾病诸如阿尔茨海默病的咪唑取代的嘧啶 For the treatment of glycogen synthase kinase 3-related diseases such as Alzheimer's disease pyrimidine substituted imidazole
05/16/2012CN102459203A 用于调控视磺醇与视黄醇结合蛋白4(rbp4)结合的组合物和方法 Depending on the regulation of sulfur alcohol and retinol-binding protein 4 (rbp4) combination compositions and methods for
05/16/2012CN102458471A 用于治疗或预防眼病的TNFα拮抗剂和VEGF拮抗剂的组合 TNFα antagonists and useful in the treatment or prevention of ocular VEGF antagonist combination
05/16/2012CN102458430A Artificial tears and therapeutic uses
05/16/2012CN102458413A Method and composition for treating macular degeneration
05/16/2012CN102458411A 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
05/16/2012CN102451439A Chinese medicinal formula for treating Meniere's syndrome
05/16/2012CN102451289A Preparation method for medlar-chrysanthemum wine
05/16/2012CN102451193A Eyewash for alleviating nyctalopia and preparation method thereof
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178499 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012CA2717605C Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
05/15/2012CA2536281C Ophthalmic composition comprising a 15-keto-prostaglandin compound
05/15/2012CA2487332C Quaternised ammonium cyclodextrin compounds for use as antimicrobial agents, preservatives and penetration enhancers
05/15/2012CA2479351C Topical composition comprising a cyclofructan, a carrier and a drug
05/15/2012CA2430978C Vla-4 inhibitors
05/10/2012WO2012061565A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/10/2012WO2012059416A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012WO2012059158A1 Composition and drug containing omega-3 fatty acids, and a modulator
05/10/2012WO2012021466A3 Use of extracts of pezizaceae in the prevention and/or treatment of senile cataracts
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 531